0001209191-23-038443.txt : 20230620 0001209191-23-038443.hdr.sgml : 20230620 20230620164809 ACCESSION NUMBER: 0001209191-23-038443 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230615 FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pellizzari Christine A CENTRAL INDEX KEY: 0001127430 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35890 FILM NUMBER: 231025907 MAIL ADDRESS: STREET 1: 10 FINDERNE AVENUE CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER NAME: FORMER CONFORMED NAME: PELLIZZARI CHRISTINE A DATE OF NAME CHANGE: 20001030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tempest Therapeutics, Inc. CENTRAL INDEX KEY: 0001544227 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451472564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415-798-8589 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: Millendo Therapeutics, Inc. DATE OF NAME CHANGE: 20181207 FORMER COMPANY: FORMER CONFORMED NAME: OvaScience, Inc. DATE OF NAME CHANGE: 20120308 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-15 0 0001544227 Tempest Therapeutics, Inc. TPST 0001127430 Pellizzari Christine A C/O TEMPEST THEARAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 400 BRISBANE CA 94005 1 0 0 0 0 Stock Option (right to buy) 1.42 2023-06-15 4 A 0 8200 0.00 A 2033-06-14 Common Stock 8200 8200 D The shares underlying the option will vest in full on the earlier of (i) June 15, 2024, or (ii) the day of the Issuer's 2024 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. /s/ Stephen Brady, Attorney-in-Fact for Christine Pellizzari 2023-06-20